Case report: Atypical young case of MV1 Creutzfeldt-Jakob disease with unusually long survival

Creutzfeldt-Jakob disease (CJD) is a rare, fatal, rapidly progressive neurodegenerative disease resulting from an accumulation of misfolded prion proteins (PrP). CJD affects 1–2 new individuals per million each year, and the sporadic type accounts for 90% of those cases. Though the median age at ons...

Full description

Saved in:
Bibliographic Details
Main Authors: Lucie Yeongran Ahn, Mark L. Cohen, Ignazio Cali, Tia Russell, Jessica Ludwig, Xun Jia, Alberto Bizzi, Lawrence B. Schonberger, Ryan A. Maddox, Rohini Paul, Tania C. Ghazarian, Jaspreet Garcha, Mostafa Hammoudi, Brian Stephen Appleby
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Cellular Neuroscience
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fncel.2024.1518542/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841561022387716096
author Lucie Yeongran Ahn
Mark L. Cohen
Mark L. Cohen
Ignazio Cali
Ignazio Cali
Tia Russell
Jessica Ludwig
Xun Jia
Alberto Bizzi
Lawrence B. Schonberger
Ryan A. Maddox
Rohini Paul
Tania C. Ghazarian
Jaspreet Garcha
Mostafa Hammoudi
Brian Stephen Appleby
Brian Stephen Appleby
Brian Stephen Appleby
Brian Stephen Appleby
author_facet Lucie Yeongran Ahn
Mark L. Cohen
Mark L. Cohen
Ignazio Cali
Ignazio Cali
Tia Russell
Jessica Ludwig
Xun Jia
Alberto Bizzi
Lawrence B. Schonberger
Ryan A. Maddox
Rohini Paul
Tania C. Ghazarian
Jaspreet Garcha
Mostafa Hammoudi
Brian Stephen Appleby
Brian Stephen Appleby
Brian Stephen Appleby
Brian Stephen Appleby
author_sort Lucie Yeongran Ahn
collection DOAJ
description Creutzfeldt-Jakob disease (CJD) is a rare, fatal, rapidly progressive neurodegenerative disease resulting from an accumulation of misfolded prion proteins (PrP). CJD affects 1–2 new individuals per million each year, and the sporadic type accounts for 90% of those cases. Though the median age at onset and disease duration vary depending on the subtype of sporadic CJD (sCJD), the disease typically affects middle-aged to elderly individuals with a median survival of 4–6 months. sCJD in younger individuals is extremely rare. Here, we present a 21-year-old female who died with a sporadic prion disease. She presented with psychiatric symptoms followed by a rapidly progressive neurocognitive and motor decline. EEG was negative for periodic sharp wave complexes; however, brain MRI was suggestive of prion disease. The cerebrospinal fluid (CSF) real-time quaking-induced conversion (RT-QuIC) assay was indeterminate. Neuropathologic examination at autopsy revealed severe neuronal loss and gliosis with secondary white matter degeneration but minimal spongiform changes and PrP deposits in the cerebellum and neocortex by immunohistochemistry. Absence of pathogenic mutations and methionine/valine heterozygosity at codon 129 of the prion protein gene (PRNP), atypical type 1 protease-resistant PrP that lacks or shows underrepresentation of the diglycosylated PrP isoform by western blot analysis, and no acquired prion disease risk factors resulted in a final diagnosis of atypical sCJD. Very young onset sCJD often has atypical clinical presentations and disease progression, neuropathological examination results, and/or laboratory test results that may confound diagnosis. It is critical to perform thorough, comprehensive evaluations to make an accurate diagnosis, which includes autopsy confirmation with histology, prion protein typing and prion gene sequencing.
format Article
id doaj-art-2ec061ded0e9484584bde93071e190e7
institution Kabale University
issn 1662-5102
language English
publishDate 2025-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cellular Neuroscience
spelling doaj-art-2ec061ded0e9484584bde93071e190e72025-01-03T06:46:58ZengFrontiers Media S.A.Frontiers in Cellular Neuroscience1662-51022025-01-011810.3389/fncel.2024.15185421518542Case report: Atypical young case of MV1 Creutzfeldt-Jakob disease with unusually long survivalLucie Yeongran Ahn0Mark L. Cohen1Mark L. Cohen2Ignazio Cali3Ignazio Cali4Tia Russell5Jessica Ludwig6Xun Jia7Alberto Bizzi8Lawrence B. Schonberger9Ryan A. Maddox10Rohini Paul11Tania C. Ghazarian12Jaspreet Garcha13Mostafa Hammoudi14Brian Stephen Appleby15Brian Stephen Appleby16Brian Stephen Appleby17Brian Stephen Appleby18Medical Scientist Training Program, Case Western Reserve University, Cleveland, OH, United StatesDepartment of Pathology, Case Western Reserve University, School of Medicine, Cleveland, OH, United StatesNational Prion Disease Pathology Surveillance Center, Case Western Reserve University, School of Medicine, Cleveland, OH, United StatesDepartment of Pathology, Case Western Reserve University, School of Medicine, Cleveland, OH, United StatesNational Prion Disease Pathology Surveillance Center, Case Western Reserve University, School of Medicine, Cleveland, OH, United StatesNational Prion Disease Pathology Surveillance Center, Case Western Reserve University, School of Medicine, Cleveland, OH, United StatesNational Prion Disease Pathology Surveillance Center, Case Western Reserve University, School of Medicine, Cleveland, OH, United StatesNational Prion Disease Pathology Surveillance Center, Case Western Reserve University, School of Medicine, Cleveland, OH, United StatesNeuroradiology Unit, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Neurologico Carlo Besta, Milan, ItalyCenters for Disease Control and Prevention (CDC), U.S. Department of Health and Human Services (USDHHS), Atlanta, GA, United StatesCenters for Disease Control and Prevention (CDC), U.S. Department of Health and Human Services (USDHHS), Atlanta, GA, United StatesDepartment of Psychiatry, Kaiser Permanente San Jose Medical Center, Graduate Medical Education, San Jose, CA, United StatesDepartment of Psychiatry, Loma Linda University School of Medicine, Graduate Medical Education, Loma Linda, CA, United StatesDepartment of Internal Medicine, Community Memorial Health Systems, Ventura, CA, United StatesDepartment of Neurology, Community Memorial Health Systems, Ventura, CA, United StatesDepartment of Pathology, Case Western Reserve University, School of Medicine, Cleveland, OH, United StatesNational Prion Disease Pathology Surveillance Center, Case Western Reserve University, School of Medicine, Cleveland, OH, United States0Department of Neurology, Case Western Reserve University, School of Medicine, Cleveland, OH, United States1Department of Psychiatry, Case Western Reserve University, School of Medicine, Cleveland, OH, United StatesCreutzfeldt-Jakob disease (CJD) is a rare, fatal, rapidly progressive neurodegenerative disease resulting from an accumulation of misfolded prion proteins (PrP). CJD affects 1–2 new individuals per million each year, and the sporadic type accounts for 90% of those cases. Though the median age at onset and disease duration vary depending on the subtype of sporadic CJD (sCJD), the disease typically affects middle-aged to elderly individuals with a median survival of 4–6 months. sCJD in younger individuals is extremely rare. Here, we present a 21-year-old female who died with a sporadic prion disease. She presented with psychiatric symptoms followed by a rapidly progressive neurocognitive and motor decline. EEG was negative for periodic sharp wave complexes; however, brain MRI was suggestive of prion disease. The cerebrospinal fluid (CSF) real-time quaking-induced conversion (RT-QuIC) assay was indeterminate. Neuropathologic examination at autopsy revealed severe neuronal loss and gliosis with secondary white matter degeneration but minimal spongiform changes and PrP deposits in the cerebellum and neocortex by immunohistochemistry. Absence of pathogenic mutations and methionine/valine heterozygosity at codon 129 of the prion protein gene (PRNP), atypical type 1 protease-resistant PrP that lacks or shows underrepresentation of the diglycosylated PrP isoform by western blot analysis, and no acquired prion disease risk factors resulted in a final diagnosis of atypical sCJD. Very young onset sCJD often has atypical clinical presentations and disease progression, neuropathological examination results, and/or laboratory test results that may confound diagnosis. It is critical to perform thorough, comprehensive evaluations to make an accurate diagnosis, which includes autopsy confirmation with histology, prion protein typing and prion gene sequencing.https://www.frontiersin.org/articles/10.3389/fncel.2024.1518542/fullsporadic CJD (sCJD)prion diseaseyoung-onset CJDrapidly progressing dementiaCreutzfeldt-Jakob disease (CJD)
spellingShingle Lucie Yeongran Ahn
Mark L. Cohen
Mark L. Cohen
Ignazio Cali
Ignazio Cali
Tia Russell
Jessica Ludwig
Xun Jia
Alberto Bizzi
Lawrence B. Schonberger
Ryan A. Maddox
Rohini Paul
Tania C. Ghazarian
Jaspreet Garcha
Mostafa Hammoudi
Brian Stephen Appleby
Brian Stephen Appleby
Brian Stephen Appleby
Brian Stephen Appleby
Case report: Atypical young case of MV1 Creutzfeldt-Jakob disease with unusually long survival
Frontiers in Cellular Neuroscience
sporadic CJD (sCJD)
prion disease
young-onset CJD
rapidly progressing dementia
Creutzfeldt-Jakob disease (CJD)
title Case report: Atypical young case of MV1 Creutzfeldt-Jakob disease with unusually long survival
title_full Case report: Atypical young case of MV1 Creutzfeldt-Jakob disease with unusually long survival
title_fullStr Case report: Atypical young case of MV1 Creutzfeldt-Jakob disease with unusually long survival
title_full_unstemmed Case report: Atypical young case of MV1 Creutzfeldt-Jakob disease with unusually long survival
title_short Case report: Atypical young case of MV1 Creutzfeldt-Jakob disease with unusually long survival
title_sort case report atypical young case of mv1 creutzfeldt jakob disease with unusually long survival
topic sporadic CJD (sCJD)
prion disease
young-onset CJD
rapidly progressing dementia
Creutzfeldt-Jakob disease (CJD)
url https://www.frontiersin.org/articles/10.3389/fncel.2024.1518542/full
work_keys_str_mv AT lucieyeongranahn casereportatypicalyoungcaseofmv1creutzfeldtjakobdiseasewithunusuallylongsurvival
AT marklcohen casereportatypicalyoungcaseofmv1creutzfeldtjakobdiseasewithunusuallylongsurvival
AT marklcohen casereportatypicalyoungcaseofmv1creutzfeldtjakobdiseasewithunusuallylongsurvival
AT ignaziocali casereportatypicalyoungcaseofmv1creutzfeldtjakobdiseasewithunusuallylongsurvival
AT ignaziocali casereportatypicalyoungcaseofmv1creutzfeldtjakobdiseasewithunusuallylongsurvival
AT tiarussell casereportatypicalyoungcaseofmv1creutzfeldtjakobdiseasewithunusuallylongsurvival
AT jessicaludwig casereportatypicalyoungcaseofmv1creutzfeldtjakobdiseasewithunusuallylongsurvival
AT xunjia casereportatypicalyoungcaseofmv1creutzfeldtjakobdiseasewithunusuallylongsurvival
AT albertobizzi casereportatypicalyoungcaseofmv1creutzfeldtjakobdiseasewithunusuallylongsurvival
AT lawrencebschonberger casereportatypicalyoungcaseofmv1creutzfeldtjakobdiseasewithunusuallylongsurvival
AT ryanamaddox casereportatypicalyoungcaseofmv1creutzfeldtjakobdiseasewithunusuallylongsurvival
AT rohinipaul casereportatypicalyoungcaseofmv1creutzfeldtjakobdiseasewithunusuallylongsurvival
AT taniacghazarian casereportatypicalyoungcaseofmv1creutzfeldtjakobdiseasewithunusuallylongsurvival
AT jaspreetgarcha casereportatypicalyoungcaseofmv1creutzfeldtjakobdiseasewithunusuallylongsurvival
AT mostafahammoudi casereportatypicalyoungcaseofmv1creutzfeldtjakobdiseasewithunusuallylongsurvival
AT brianstephenappleby casereportatypicalyoungcaseofmv1creutzfeldtjakobdiseasewithunusuallylongsurvival
AT brianstephenappleby casereportatypicalyoungcaseofmv1creutzfeldtjakobdiseasewithunusuallylongsurvival
AT brianstephenappleby casereportatypicalyoungcaseofmv1creutzfeldtjakobdiseasewithunusuallylongsurvival
AT brianstephenappleby casereportatypicalyoungcaseofmv1creutzfeldtjakobdiseasewithunusuallylongsurvival